NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

I'd call it false progression to avoid confusion with Phase III brain tumor patient's psuedo-progression since I don't believe that psuedo-progression was caused by DCVax L but was already present.

Now that we know about the false progression issue, that information can be included in the informed consent for patients enrolling in the Phase 2 trial.

That way the patients will know about false progression is and what it may mean and will not almost get scared out of staying in the trial by a radiologist unfamiliar with cancer immunotherapy (as in the case Dr. Bosch related at ASCO).